218 related articles for article (PubMed ID: 29666143)
21. Identification of 29 novel and nine recurrent fibrillin-1 (FBN1) mutations and genotype-phenotype correlations in 76 patients with Marfan syndrome.
Rommel K; Karck M; Haverich A; von Kodolitsch Y; Rybczynski M; Müller G; Singh KK; Schmidtke J; Arslan-Kirchner M
Hum Mutat; 2005 Dec; 26(6):529-39. PubMed ID: 16220557
[TBL] [Abstract][Full Text] [Related]
22. A mutation in FBN1 disrupts profibrillin processing and results in isolated skeletal features of the Marfan syndrome.
Milewicz DM; Grossfield J; Cao SN; Kielty C; Covitz W; Jewett T
J Clin Invest; 1995 May; 95(5):2373-8. PubMed ID: 7738200
[TBL] [Abstract][Full Text] [Related]
23. Renal cystic disease in the Fbn1
Hibender S; Wanga S; van der Made I; Vos M; Mulder BJ; Balm R; de Vries CJ; de Waard V
Cardiovasc Pathol; 2019; 38():1-6. PubMed ID: 30359839
[TBL] [Abstract][Full Text] [Related]
24. Male Marfan mice are predisposed to high-fat diet-induced obesity, diabetes, and fatty liver.
Tiedemann K; Muthu ML; Reinhardt DP; Komarova SV
Am J Physiol Cell Physiol; 2022 Aug; 323(2):C354-C366. PubMed ID: 35759435
[TBL] [Abstract][Full Text] [Related]
25. Marfan syndrome type II: there is more to Marfan syndrome than fibrillin 1.
Zangwill SD; Brown MD; Bryke CR; Cava JR; Segura AD
Congenit Heart Dis; 2006 Sep; 1(5):229-32. PubMed ID: 18377530
[TBL] [Abstract][Full Text] [Related]
26. A Novel Fibrillin-1 Gene Mutation Leading to Marfan Syndrome in a Korean Girl.
Nam HK; Nam MH; Ha KS; Rhie YJ; Lee KH
Ann Clin Lab Sci; 2017 Mar; 47(2):221-225. PubMed ID: 28442527
[TBL] [Abstract][Full Text] [Related]
27. Relation between genotype and left-ventricular dilatation in patients with Marfan syndrome.
Aalberts JJ; van Tintelen JP; Meijboom LJ; Polko A; Jongbloed JD; van der Wal H; Pals G; Osinga J; Timmermans J; de Backer J; Bakker MK; van Veldhuisen DJ; Hofstra RM; Mulder BJ; van den Berg MP
Gene; 2014 Jan; 534(1):40-3. PubMed ID: 24161884
[TBL] [Abstract][Full Text] [Related]
28. Loss of elastic fiber integrity and reduction of vascular smooth muscle contraction resulting from the upregulated activities of matrix metalloproteinase-2 and -9 in the thoracic aortic aneurysm in Marfan syndrome.
Chung AW; Au Yeung K; Sandor GG; Judge DP; Dietz HC; van Breemen C
Circ Res; 2007 Aug; 101(5):512-22. PubMed ID: 17641224
[TBL] [Abstract][Full Text] [Related]
29. A novel mutation in the fibrillin gene (FBN1) in familial arachnodactyly.
Hayward C; Porteous ME; Brock DJ
Mol Cell Probes; 1994 Aug; 8(4):325-7. PubMed ID: 7870075
[TBL] [Abstract][Full Text] [Related]
30. A Marfan syndrome human induced pluripotent stem cell line with a heterozygous FBN1 c.4082G>A mutation, ISMMSi002-B, for disease modeling.
Klein S; Dvornik JL; Yarrabothula AR; Schaniel C
Stem Cell Res; 2017 Aug; 23():73-76. PubMed ID: 28925368
[TBL] [Abstract][Full Text] [Related]
31. Generation of Marfan patient specific iPSCs (ICSSUi001-A) carrying a novel heterozygous mutation in FBN1 gene.
Yu Y; Shen H; Zhu J; Cao X; Li Q; Shao L; Shen Z
Stem Cell Res; 2022 Apr; 60():102720. PubMed ID: 35231796
[TBL] [Abstract][Full Text] [Related]
32. Dural ectasia and FBN1 mutation screening of 40 patients with Marfan syndrome and related disorders: role of dural ectasia for the diagnosis.
Attanasio M; Pratelli E; Porciani MC; Evangelisti L; Torricelli E; Pellicanò G; Abbate R; Gensini GF; Pepe G
Eur J Med Genet; 2013 Jul; 56(7):356-60. PubMed ID: 23684891
[TBL] [Abstract][Full Text] [Related]
33. Skeletal manifestations of Marfan syndrome associated to heterozygous R2726W FBN1 variant: sibling case report and literature review.
Reyes-Hernández OD; Palacios-Reyes C; Chávez-Ocaña S; Cortés-Malagón EM; Alonso-Themann PG; Ramos-Cano V; Ramírez-Bello J; Sierra-Martínez M
BMC Musculoskelet Disord; 2016 Feb; 17():79. PubMed ID: 26875674
[TBL] [Abstract][Full Text] [Related]
34. Evidence for a critical contribution of haploinsufficiency in the complex pathogenesis of Marfan syndrome.
Judge DP; Biery NJ; Keene DR; Geubtner J; Myers L; Huso DL; Sakai LY; Dietz HC
J Clin Invest; 2004 Jul; 114(2):172-81. PubMed ID: 15254584
[TBL] [Abstract][Full Text] [Related]
35. Cardiovascular characteristics in Marfan syndrome and their relation to the genotype.
De Backer J
Verh K Acad Geneeskd Belg; 2009; 71(6):335-71. PubMed ID: 20232788
[TBL] [Abstract][Full Text] [Related]
36. DNA methylation ambiguity in the Fibrillin-1 (FBN1) CpG island shore possibly involved in Marfan syndrome.
Arai Y; Umeyama K; Okazaki N; Nakano K; Nishino K; Nagashima H; Ohgane J
Sci Rep; 2020 Mar; 10(1):5287. PubMed ID: 32210272
[TBL] [Abstract][Full Text] [Related]
37. Exogenous activation of BMP-2 signaling overcomes TGFβ-mediated inhibition of osteogenesis in Marfan embryonic stem cells and Marfan patient-specific induced pluripotent stem cells.
Quarto N; Li S; Renda A; Longaker MT
Stem Cells; 2012 Dec; 30(12):2709-19. PubMed ID: 23037987
[TBL] [Abstract][Full Text] [Related]
38. Marfan syndrome--a diagnostic challenge caused by phenotypic and genetic heterogeneity.
Baumgartner C; Mátyás G; Steinmann B; Baumgartner D
Methods Inf Med; 2005; 44(4):487-97. PubMed ID: 16342915
[TBL] [Abstract][Full Text] [Related]
39. Generation of human induced pluripotent stem cell line UGENTi001-A from a patient with Marfan syndrome carrying a heterozygous c.7754 T > C variant in FBN1 and the isogenic control UGENT001-A-1 using CRISPR/Cas9 editing.
Aalders J; Léger L; Demolder A; Muiño Mosquera L; Coucke P; Menten B; De Backer J; van Hengel J
Stem Cell Res; 2023 Mar; 67():103036. PubMed ID: 36724552
[TBL] [Abstract][Full Text] [Related]
40. Generation of an induced pluripotent stem cell (iPSC) line of a Marfan syndrome patient with a pathogenic FBN1 c.5372G > A (p.Cys1791Tyr) variant.
Peeters S; Fedoryshchenko I; Rabaut L; Verstraeten A; Loeys BL
Stem Cell Res; 2023 Apr; 68():103050. PubMed ID: 36801568
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
